6-158111108-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_032861.4(SERAC1):c.*258G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 259,010 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0015 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 1 hom. )
Consequence
SERAC1
NM_032861.4 3_prime_UTR
NM_032861.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.372
Genes affected
SERAC1 (HGNC:21061): (serine active site containing 1) The protein encoded by this gene is a phosphatidylglycerol remodeling protein found at the interface of mitochondria and endoplasmic reticula, where it mediates phospholipid exchange. The encoded protein plays a major role in mitochondrial function and intracellular cholesterol trafficking. Defects in this gene are a cause of 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL). Two transcript variants, one protein-coding and the other non-protein coding, have been found for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 6-158111108-C-T is Benign according to our data. Variant chr6-158111108-C-T is described in ClinVar as [Benign]. Clinvar id is 2500852.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00149 AC: 227AN: 152186Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
227
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00100 AC: 107AN: 106706Hom.: 1 Cov.: 2 AF XY: 0.000940 AC XY: 51AN XY: 54250
GnomAD4 exome
AF:
AC:
107
AN:
106706
Hom.:
Cov.:
2
AF XY:
AC XY:
51
AN XY:
54250
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00149 AC: 227AN: 152304Hom.: 3 Cov.: 32 AF XY: 0.00228 AC XY: 170AN XY: 74456
GnomAD4 genome
AF:
AC:
227
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
170
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Benign:1
Benign, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The heterozygous c.*258G>A variant in SERAC1 was identified by our study, in the compound heterozygous state, along with a likely pathogenic variant (ClinVar Variation ID: 938842), in one individual with neonatal 3-methylglutaconic aciduria, muscular spasticity, and multi-organ insufficiency. Trio exome analysis revealed this variant to be in trans with a likely pathogenic variant (ClinVar Variation ID: 938842). The c.*258G>A variant in SERAC1 has not been previously reported in individuals with 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome but has been identified in 2% (210/10606) of European (Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs185841896). This variant was detected in 3 control individuals of the European (Finnish) population by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs185841896), suggesting that this variant is not pathogenic for 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome. Computational prediction tools, including splice predictors, and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the c.*258G>A variant is uncertain, these data suggest that it is more likely to be benign. ACMG/AMP Criteria applied: PM3, BS1, BS2, BP4 (Richards 2015). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at